Adjuvant treatment with IL-2 or interferon-alpha in renal cell carcinoma: a French multicentric study.
Soret
J Y
JY
CHU Angers, Villejuif, France.
Escudier
B
B
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*
D016898:Interferon-alpha; D007376:Interleukin-2